Skin News and Research

RSS

Helix BioMedix reports recorded revenue of $70,000 for first-quarter 2010

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the company's first quarter 2010 ended March 31, 2010.

7 May 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

NewCardio, Inc., a cardiac diagnostic technology provider, will unveil its patented CardioBip technology for remote wireless 12-lead detection and monitoring of atrial fibrillation, ischemia and other cardiovascular events at the Heart Rhythm Society 31st Annual Scientific Sessions, May 12-15, 2010, in Denver, Colorado.

7 May 2010

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

In the last three years, a new technique for reprogramming adult cells has given scientists an easier and less controversial way to harness the power of embryonic-like stem cells to study human disease from its earliest beginnings in hopes of gleaning new insights into the root causes of disease and developing new therapies.

7 May 2010

MicroStockProfit.com releases NexMed investment report

MicroStockProfit.com announces an investment report featuring NexMed Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 May 2010

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.

7 May 2010

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.

7 May 2010

The emerging science of epigenetics

Human embryonic stem cells (hESCs) possess remarkable properties of self-renewal and pluripotency, the ability to become almost any kind of cell within the body. And yet they share the same genome or set of genes with lineage-committed cells, cells fated to be or do one thing.

7 May 2010

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Amira Pharmaceuticals, Inc. announced today that preclinical data from its LPA1 receptor antagonist program has been published in the British Journal of Pharmacology.

7 May 2010

Prescription drug may have new use in boosting effectiveness of vaccines for bacterial, viral diseases

A prescription drug already approved to treat genital warts and skin cancer may have a new use in boosting the effectiveness of future vaccines for bacterial and viral diseases, such as hepatitis C and HIV (the AIDS virus). These findings appear in ACS' Molecular Pharmaceutics, a bi-monthly journal.

6 May 2010

Global warming could lead to deadly temperatures for humans in coming centuries: Research

Reasonable worst-case scenarios for global warming could lead to deadly temperatures for humans in coming centuries, according to research findings from Purdue University and the University of New South Wales, Australia.

6 May 2010

Southeast Pain Care offers non-addictive alternatives to pain relief

The untimely death of Michael Jackson has brought the issue of pain medication addiction to the forefront of American media recently. The good news for people suffering with pain is that there are several non-addictive alternatives to pain relief.

6 May 2010

Patients Medical provides patients with valuable tips to prevent Lyme disease

Patients Medical, a leading integrative and holistic medical center in New York City, is supporting National Lyme Disease Awareness month by providing patients with valuable tips to prevent the disease, as well as education on the best treatment options available.

6 May 2010

Cohera Medical reports top-line results from Tissuglu clinical trial

Cohera Medical, Inc.® today announced that top-line clinical study results demonstrate the safety and preliminary effectiveness of the company's lead surgical adhesive product, TissuGlu®.

6 May 2010

New study reveals facial skin cancer occurs predominantly on left-side

In a study appearing in the Journal of the American Academy of Dermatology a Saint Louis University doctor found that facial skin cancers were predominantly on the left-side, and especially in men.

6 May 2010

SAEC, Cerner collaborate to identify genetic markers associated with drug-related SAEs

The International Serious Adverse Events Consortium (SAEC) announced today that Cerner Corporation will collaborate with this novel, international research consortium, which is working to identify genetic markers that may help predict which individuals are at risk for a range of serious drug-related adverse events (SAEs). Researchers collaborating with the SAEC will use Cerner Discovere-, Cerner's web-based research platform, to gather data for studies that focus on two SAEs: liver injury and hypersensitivity reactions.

6 May 2010

Positive results from Phase IIa clinical study of LIPO-102

Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate and fluticasone propionate for selective, non-ablative fat reduction. LIPO-102 was well-tolerated when administered weekly for 8 weeks into the subcutaneous abdominal fat of healthy subjects.

6 May 2010

Making stem cells in the lab: a training program and a study

Young researchers will now be trained for the first time by the Australian Stem Cell Centre (ASCC) in scientific techniques of using and growing human induced pluripotent stem (iPS) cells in research. This training will be through StemCore iPS Cell Workshop, the ASCC's national facility for the provision of stem cells and advice.

5 May 2010

AAA symposium features digital technologies in anatomical reconstruction

Techniques for using digital technology in separating conjoined twins, developing facial prostheses and acquiring data from anthropologic specimens will be among the topics presented at a symposium sponsored by the American Association of Anatomists (AAA; www.Anatomy.org) on April 28. The symposium is part of the Experimental Biology 2010 conference being held April 24-28, 2010 at the Anaheim Convention Center.

5 May 2010

Three Hamilton scientists receive cancer research grants from Canadian Cancer Society

Three Hamilton scientists are receiving new funding from the Canadian Cancer Society for their work in innovative cancer research.

5 May 2010

Americans and their babies are gaining more body fat: Study

A new study has found for the first time that as Americans are gaining more body fat, so are their babies. The research, which reviewed data from more than 74,000 births, found that a key measure of body fat composition in newborns increased significantly over a 15-year period, mirroring similar increases among pregnant mothers. The findings were presented Sunday by researchers from Children's Mercy Hospitals and Clinics at the Pediatric Academic Societies annual meeting.

5 May 2010

Skin News and Research

Helix BioMedix reports recorded revenue of $70,000 for first-quarter 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

MicroStockProfit.com releases NexMed investment report

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

The emerging science of epigenetics

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Prescription drug may have new use in boosting effectiveness of vaccines for bacterial, viral diseases

Global warming could lead to deadly temperatures for humans in coming centuries: Research

Southeast Pain Care offers non-addictive alternatives to pain relief

Patients Medical provides patients with valuable tips to prevent Lyme disease

Cohera Medical reports top-line results from Tissuglu clinical trial

New study reveals facial skin cancer occurs predominantly on left-side

SAEC, Cerner collaborate to identify genetic markers associated with drug-related SAEs

Positive results from Phase IIa clinical study of LIPO-102

Making stem cells in the lab: a training program and a study

AAA symposium features digital technologies in anatomical reconstruction

Three Hamilton scientists receive cancer research grants from Canadian Cancer Society

Americans and their babies are gaining more body fat: Study

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News